MECP2 and Rett syndrome: We also demonstrate that pentobarbital (PB) can reverse the structural and synaptic phenotypes resulting from MeCP2 deficiency, revealing the potential of γ-aminobutyric acid (GABA) A receptor (GABAAR) modulators such as PB as novel therapeutic treatments for RTT in the future